|
Q4 2019
Filed on Feb 10, 2020
|
47,200
|
$47.39 - $63.47
$2.24M - $3M
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
214,967
|
$6.18 - $7.18
$1.33M - $1.54M
|
|
Protalix Biotherapeutics Inc
|
Q4 2019
Filed on Feb 10, 2020
|
36,381
|
N/A
|
|
Invesco Exch Trd Slf Idx Fd
|
Q4 2019
Filed on Feb 10, 2020
|
61,567
|
N/A
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
42,392
|
$51.74 - $58.29
$2.19M - $2.47M
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
88,500
|
$26.36 - $30.2
$2.33M - $2.67M
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
47,200
|
$47.39 - $63.47
$2.24M - $3M
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
17,146
|
$17.95 - $21.25
$308K - $364K
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
49,361
|
N/A
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
14,848
|
$74.6 - $90.52
$1.11M - $1.34M
|
|
Invesco Exch Trd Slf Idx Fd
|
Q4 2019
Filed on Feb 10, 2020
|
88
|
N/A
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
40,083
|
$63.34 - $74.11
$2.54M - $2.97M
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
38,888
|
$15.87 - $23.12
$617K - $899K
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
34,626
|
$27.83 - $39.32
$964K - $1.36M
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
52,969
|
N/A
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
10,256
|
$226.39 - $247.98
$2.32M - $2.54M
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
22,068
|
N/A
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
9,875
|
N/A
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
41,300
|
$42.35 - $49.34
$1.75M - $2.04M
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
47,200
|
N/A
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
12,852
|
N/A
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
7,430
|
$35.66 - $37.34
$265K - $277K
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
1,469,752
|
N/A
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
8,816
|
$129.97 - $148.41
$1.15M - $1.31M
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
31,394
|
$32.08 - $36.79
$1.01M - $1.15M
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
14,400
|
$13.93 - $14.31
$201K - $206K
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
14,529
|
N/A
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
14,901
|
N/A
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
11,800
|
N/A
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
25,430
|
$44.85 - $55.43
$1.14M - $1.41M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
1,100
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
475
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
25,750
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
2,032
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
850
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
1,400
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
59,474
|
$20.59 - $25.24
$1.22M - $1.5M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
16,101
|
$5.83 - $10.77
$93.9K - $173K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
21,912
|
$33.12 - $38.72
$726K - $848K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
40,172
|
$12.61 - $13.64
$507K - $548K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
13,104
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
26,298
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
20,851
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
8,358
|
$130.56 - $181.87
$1.09M - $1.52M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
20,750
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
3,851
|
$642.84 - $872.45
$2.48M - $3.36M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
3,665
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
11,094
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
12,699
|
$39.98 - $48.85
$508K - $620K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
7,377
|
$34.44 - $39.52
$254K - $292K
|
|